International Clinical Trial: A Safety and Pharmacokinetics Study of TL-001 in Healthy Adults and Open-label Assessments in Participants With Ulcerative Colitis

Geneva, April 20 -- International Clinical Trials Registry received information related to the study (NCT07526519) titled 'A Safety and Pharmacokinetics Study of TL-001 in Healthy Adults and Open-label Assessments in Participants With Ulcerative Colitis' on April 6.

Study Type: Interventional

Study Design: Allocation: Randomized. Intervention model: Sequential Assignment. Primary purpose: Treatment. Masking: Double (Participant, Investigator).

Primary Sponsor: TrueLab Biopharmaceutical Co., Ltd

Condition: Healthy Volunteer

Intervention: Drug: TL-003

Recruitment Status: Recruiting

Phase: Phase 1

Date of First Enrollment: April 2026

Target Sample Size: 48

Countries of Recruitment: Australia

To know more, visit https://clin...